WO2005095394A1

WO2005095394A1 - A process for the semisynthesis of deserpidine

Info

Publication number: WO2005095394A1
Application number: PCT/EP2005/002190
Authority: WO
Inventors: Gabriele Fontana; Ezio Bombardelli; Cristian Samori; Eleonora Baldelli; Andrea Guerrini; Arturo Battaglia; Bruno Danieli
Original assignee: Indena S.P.A.
Priority date: 2004-03-25
Filing date: 2005-03-02
Publication date: 2005-10-13
Also published as: ITMI20040582A1; CN100475811C; JP2007530467A; JP4841542B2; CA2560778C; EP1737855B1; ES2308452T3; PL1737855T3; SI1737855T1; DK1737855T3; CA2560778A1; ATE399167T1; WO2005095394A8; KR101087461B1; IL178228A; RU2372351C2; RU2006133740A; IL178228A0; AU2005229344B2; PT1737855E

Abstract

The present invention relates to an efficient procedure for the synthesis of deserpidine (Ia), starting from reserpic acid lactone (II) via the intermediate 11-O-demethyl reserpic acid lactone (III).

Description

A PROCESS FOR THE SEMISYNTHESIS OF PESERPIDINE

FIELD OF THE INVENTION The present invention relates to indole alkaloids, in particular to a process for the synthesis of deserpidine. Background of the invention Reserpine (lb) was isolated for the first time in 1952 from Rauwolβa serpentina extracts by Schiitter (Muller et al, Experientia 1952, 8, 338) and identified as the main responsible for the ipotensive activity of Rauwolβa spp extracts.

Deserpidine (la) was isolated for the first time in 1955 from Rauwolβa canescens roots by Hofmann (Stoll and Hofmann, /. Am. Chem. Soc. 1955, 77, 820).

Over the years reserpine and related indole alkaloids, such as deserpidine, have played an important role in the treatment of hypertensive, nervous and mental disorders. Even if deserpidine has an interesting pharmacological profile, its use has always been limited compared with reserpine due to its poor availability in nature. In fact, deserpidine titre in the cortical part of the roots is of about 0.003-0.005%, whilst reserpine titre is of about 0.1-0.2%. Deserpidine is structurally related to reserpine (lb) and rescinammine (Ic).

Compared to reserpine, deserpidine lacks the methoxy group at the 11-position. Compared to rescinnamine, deserpidine lacks the methoxy group at the 11-position and is esterified at the 18-position with a 3,4,5- trimethoxybenzoic residue instead of a 3,4,5-trimethoxycinnamic residue. Theoretically, the conversion of reserpine to deserpidine could be carried out through demethoxylation of the 11-position. According to known organic chemistry methods, the easiest way could be either the direct demethoxylation of reserpine or the conversion of the 11-methoxy group to hydroxy group, followed by reduction of the phenol ring to benzene ring. It is known to those skilled in the art that the polyfunctionalization of reserpine, rescinnamine and methyl reserpate (Id)

does not allow selective O-demethylation of the hydroxy group at the 11-position. The known methods for direct 11-demethoxyation or 11-0- demethylation lack regioselectivity and/or chemoselectivity. It has now been found that these problems can be overcome using reserpic acid lactone as the precursor.

Detailed description of the invention The present invention relates to a process for the synthesis of deserpidine which comprises demethylation of reserpic acid lactone, conversion of the phenol ring to benzene ring and re-esterification of the 18-hydroxy group. In more detail, the process comprises the following steps: a) demethylation of reserpic acid lactone (II)

to give 11-O-demethyl reserpic acid lactone (III)

b) conversion of compound (III) to deserpidic acid lactone (V)

c) hydrolisis of deserpidic acid lactone (V) to methyl deserpidate (VI)

d) esterification of methyl deserpidate (VI) with 3,4,5- trimethoxybenzoic acid to give deserpidine (la)

Reserpic acid lactone is a known compound and can be conveniently prepared by hydrolysis of reserpine or rescinnamine, or a mixture thereof, with sodium methoxide to methyl reserpate (Id)

which is then cyclized to the corresponding lactone with a procedure similar to the one reported by Woodward (R.B. Woodward et al, Tetrahedron 1958, 2, 1-57). Alternatively, reserpine and rescinnamine can be directly converted to their corresponding lactons according to the literature (H.B. MacPhillamy et al., J. Am. Chem. Soc, 1955, 77, 4335-4343). The selective demethylation of reserpic acid lactone (step a) can be carried out with conventional demethylating agents, preferably selected from boron tribromide, iodotrimethylsilane and hydriodic acid under reaction conditions that can easily be optimised by the skilled chemist, provided that the lactone' s stability is ensured. The use of boron tribromide is particularly preferred, as described in the reported example. Step b) can be carried out with methods suitable for reducing phenol to benzene. Preferably, this step is carried out transforming compound (III) in a compound of formula (IV)

in which R' is a leaving group and reducing (IV). Among the leaving groups, sulfonic esters, such as tosylate or mesylate, isoureido groups (under the conditions described by Vowinkel in E. Vowinkel et al., Chem. Ber. 1974, 107, 907-914) are preferred, for example those obtained by treatment with dicyclohexylcarbodiimide or diisopropylcarbodiimide, or the (5-phenyl-tetrazolyl)oxy group (obtained by treatment with l-chloro-5-phenyl-tetrazole under the conditions described by W.J. Musliner et al. J. Am. Chem. Soc. 1959, 81, 4271-4273). Particularly preferred is the tosylate group, as described in the reported example. The reducing agent is, for example, selected from nickel Raney, palladium on charcoal and platinum. Nickel Raney must be used to reduce sulfonic esters, whereas palladium on charcoal is preferred for the reduction of isoureas, for example those obtained with dicyclohexylcarbodiimide or diisopropylcarbodiimide. The hydrolysis of deserpidic acid lactone to methyl deserpidate (step c) can be carried out with sodium methoxide in alcohols and the esterification of methyl deserpidate to deserpidine (step d) is carried out under conditions analogous to those reported in literature (H.B. MacPhillamy et al., J. Am. Chem. Soc, 1955, 77, 4335-4343; M. Lounasmaa et. al., Heterocycles 1985, 23, 371-375; R.H. Levin et al., J. Org. Chem. 1973, 38, 1983-1986). Therefore, the use of reserpic acid lactone as precursor allows to overcome the regio- and chemoselectivity problems of the known processes. In fact, in the lactone, the conformation of the 16-, 17- and 18- substituents is such that the 17-methoxy group is in the axial position, while in the precursors is in the equatorial position; the axial conformation shields the methoxy group from the attack of demethylating reagents and allows selective demethylation of the 11 -position with respect to the 17-position. The process of the invention provides a minimum yield of 40%. The following examples illustrate the invention in greater detail. Examples Example 1. Synthesis of methyl reserpate A suspension of reserpine (1 g, 0.16 mmol) in a solution of sodium methoxide (0.150 g, 4.8 mmol) in methanol (50 ml) was refluxed until disappearance of the starting material (1 h), then cooled and concentrated under vacuum to one third of the volume. The solution was diluted with water (60 ml) and pH was adjusted to 1 with concentrated hydrochloric acid. The aqueous solution was then repeatedly washed with ethyl ether. The aqueous phase was then alkalinized with concentrated ammonia and repeatedly extracted with methylene chloride (4 x 30 ml). The combined organic phases were dried over sodium sulfate and concentrated under vacuum to give an amorphous residue (0.66 g), used for the following step without any further purification. The same process was followed starting from equivalent amounts of rescinnamine. Example 2. Synthesis of reserpic acid lactone A) From reserpine Reserpine (4.1 g, 6.74 mmol) was added under stirring to a solution of aluminium isopropoxide (10.5 g, 51.4 mmol) in xylene (175 ml) and the resulting mixture was refluxed under nitrogen for 6 hours. The reserpic acid lactone precipitated from the solution was filtered and washed with benzene (3 x 40 ml), followed by ethyl ether (4 x 40 ml). The residue was recrystallized from CHC1₃ affording 2.07 g (5.45 mmol, 81%) of the desired product. The same procedure was applied to rescinnamine.

B) From methyl reserpate Aluminium isoperoxide (0.747 g, 3.65 mmol) was dissolved under nitrogen in xylene (11.0 ml). Methyl reserpate (0.200 g, 0.483 mmol) was added and the reaction mixture was refluxed with stirring. The ester dissolved quickly and the lactone started to separate as a white solid after 5'. After 2 h under reflux the product was separated by filtration and washed with xylene (3 x 20 ml), and ether (3 x 20 ml). The residue was recrystallized from CHC1₃ affording 0.168 g (0.440 mmol, 91%) of the desired product. 1H NMR (DMSO-d₆, 400 MHz) δ 10.5 (bs, 1H, NH , 7.18 (d, 1 H,

J = 8.4 Hz, H-9), 6.77 (d, 1 H, J = 2.3 Hz, H-12), 6.58 (dd, 1 H, 7 = 8.4 Hz, J₂ = 2.3 Hz, H-10), 4.75 (m, 1 H, J = 4.3 Hz), 4.10 (t, 1 H, J = 5 Hz, H-17), 3.73 (s, 3H, OMe), 3.45 (d, 1 H, J = 12.0 Hz, H-3), 3.35 (s, 3 H, OMe), 2.90 (dd, 1 H, Jj = 11.0 Hz, J₂ = 5.2 Hz), 2.76-2.63 (m, 1 H), 2.62-2.45 (m, 5 H), 2.43-2.24 (m, 3 H), 2.00 (m, 1 H, J, = 15.0 Hz, J₂ = 8.6 Hz), 1.73 (m, 1 H), 1.56 (m, 1 H, Jj = 15.0 Hz, J₂ = 4.1 Hz, H-19); ¹³C NMR (DMSO-d₆, 100 MHz) δ 178.3, 155.7, 137.5, 135.2, 121.9, 118.6, 108.5, 106.7, 95.5, 77.7, 77.1, 58.8, 57.1, 55.9, 54.9, 53.2, 45.5, 35.4, 31.3, 27.7, 26.4, 22.2. Example 3. Synthesis of 11-O-demethvI reserpic acid lactone Reserpic acid lactone (0.210 g, 0.550 mmol) was suspended under argon in anhydrous CH₂C1₂ (8.0 ml) and the mixture was cooled to 0°C. After 15' boron tribromide was added (1.4 ml, 1.37 mmol, 1.0 M solution in CH₂C1₂) and the solution turned brick red. After 5 h the reaction was quenched with a NaHC0₃ saturated solution and extracted with CH₂C1₂. The aqueous phases were collected and extracted again with AcOEt (3 x 15.0 ml). The organic phases were combined and dried. The aqueous phase was filtered, the precipitate was redissolved in a 1 : 1 THF/MeOH mixture, and added to the previously obtained organic solution. After filtration and concentration under vacuum the solid residue was chromatographed (silica gel, CH₂Cl₂ MeOH = 15:1, then 16:1) to give the desired product (0.187 g, 0. 51 mmol, 92%). 1H NMR (THF-d₈, 400 MHz) δ 9.38 (bs, 1 H, NH), 7.54 (bs, 1 H, OH), 7.07 (d, 1 H, X 8.4 Hz, H-9), 6.59 (d, 1 H, J= 2.2 Hz, H-12), 6.44 (dd, 1 H, J; = 8.4 Hz, J₂ = 2.2 Hz, H-10), 4.63 (t, 1 H, J = 4.3 Hz, H-18), 4.03 (t, 1 H, J = 5.2 Hz, H-17), 3.61 (d, 1 H, H-3), 3.40 (s, 3 H, OMe), 2.90 (m, 1 H), 2.86-2.46 (m, 7 H), 2.38 (m, 1 H), 2.22 (dd, 1 H, J, = 13.5 Hz, J₂ = 2.0 Hz), 2.11 (m, 1 H, Jj = 14.9 Hz, J₂ = 8.5 Hz), 1.86 (m, 1 H), 1.61 (dd, 1 U, Jj = 14.8 Hz, J₂ = 3.9 Hz, H-19); ¹³C NMR (THF-d₈, 100 MHz) δ 176.6, 153.2, 138.0, 133.9, 121.3, 117.5, 108.4, 106.9, 96.6, 78.2, 76.7, 58.9, 56.2, 54.6, 53.1, 45.7, 35.8, 31.8, 27.9, 26.2, 22.1. Example 4. Synthesis of 11-O-p-toIuenesuIfonyl-ll-O-demethyl reserpic acid lactone 11-0-Demethyl reserpic acid lactone (0.700 g, 1.90 mmol) was dissolved under nitrogen in 65 ml of anhydrous THF, then triethylamine was added (1.86 ml, 13.32 mmol). The reaction mixture was reacted for 10', added with p-toluenesulfonyl chloride (1.09 g, 5.71 mmol), then refluxed for 42 h. The reaction mixture was evaporated under vacuum and the residue was chromatographed (silica gel, CH₂Cl₂/MeOH = 17:1), to afford 0.75 g of the desired compound (0.75 g, 1.44 mmol 76%). 1H NMR (THF-d₈, 400 MHz) δ 9.99 (bs, 1 H, NH), 7.63 (2 H, Ar), 7.31 (2 H, Ar), 7.15 (d, 1 H, J= 8.4 Hz, H-9), 6.90 (d, 1 H, J= 2.2 Hz, H-12), 6.47 (dd, 1 H, J] = 8.4 Hz, J₂ = 2.2 Hz, H-10), 4.64 (t, 1 H, J = 4.1 Hz, H-18), 4.03 (t, 1 H, J = 5.2 Hz, H-17), 3.62 (d, 1 H, J= 1 1.8 Hz, H-3), 3.39 (s, 3 H, OMe), 2.91 (m, 1 H), 2.84-2.43 (m, 7 H), 2.38 (m, 4 H, 1 Me and 1 H), 2.22 (dd, 1 H, Jj = 13.5 Hz, J₂ = 2.0 Hz), 2.10 (m, 1 H, J_} = 15.0 Hz, J₂ = 8.5 Hz), 1.86 (m, 1 H), 1.60 (dd, 1 H, Jj = 15.0 Hz, J₂ = 4.0 Hz, H- 19); ¹³C-NMR (THF-d₈, 100 MHz) δ 176.7, 144.9, 144.8, 136.2, 133.5, 129.6, 128.7, 126.3, 117.4, 113.2, 107.5, 105.0, 78.2, 76.7, 58.8, 56.3, 54.5, 52.9, 45.7, 35.7, 31.7, 29.9, 27.9, 26.2, 21.9, 20.8. Example 5. Synthesis of deserpidic acid lactone Ni-Raney, previously washed with H₂0 (twice), MeOH (twice) and

EtOH (once) was introduced (4.86 g, humid) into a hydrogenation reactor

under argon, followed by 11-O- -toluenesulfonyl-l l-O-demethylreserpic acid lactone (0.300 g, 0.58 mmol), dissolved in 14 ml of anhydrous THF and 16.0 ml of EtOH. The hydrogenation was carried out under a pressure of

50 psi. After 8 h the solution was filtered through Celite, washed with CHC1₃

(6 x 40 ml) and 100 ml of MeOH. The solvent was evaporated under vacuum and the residue was chromatographed (silica gel, CH₂Cl₂/MeOH = 20: 1), to afford 0.17 g of the desired compound (0.170 g, 0.49 mmol, 85%). 1H NMR (THF-d₈, 400 MHz) δ 9.80 (bs, 1H, NH), 7.32 (d, 1 H, J= 7.8

Hz, H-9), 7.20 (d, 1 H, J= 7.6 Hz, H-12), 6.98-6.87 (m, 2 H, Ar, H-10, H-l 1), 4.04 (t, 1 H, J = 5.2 Hz, H-17), 3.66 (d, 1 H, J = 11.8 Hz, H-3), 3.40 (s, 3H, OMe), 2.94 (m, 1 H), 2.84 (m, 1H), 2.78-2.33 (m, 7H), 2.28 (dd, 1 H, Jj = 13.7 Hz, J₂ = 2.0 Hz), 2.12 (m, 1 H, Jj = 15.0 Hz, J₂ = 8.5 Hz), 1.89 (m, 1 H), 1.62 (dd, 1 U, Jj = 14.8 Hz, J₂ = 4.0 Hz, H-19); ¹³C-NMR (THF-d₈, 100 MHz) δ 176.7, 136.9, 136.1, 127.6, 120.2, 118.3, 117.4, 110.5, 107.2, 78.2, 76.7, 58.9, 56.2, 54.6, 53.1, 45.7, 35.8, 31.7, 27.9, 26.2, 22.1. Example 6. Synthesis of methyl deserpidate Deserpidic acid lactone (0.140 g, 0.398 mmol) was dissolved under nitrogen in 27.0 ml of anhydrous MeOH. This suspension was added with MeONa (0.032 g, 0.597 mmol), then the mixture was reacted under reflux for 90'. The reaction was quenched adding 0.2 ml of glacial acetic acid and the solvent was evaporated under vacuum. The resulting product was redissolved with a 0.2 M NaOH solution and extracted with CHC1₃ (4 x 25 ml); the organic phase was dried and filtered. The solvent was evaporated under vacuum and the residue was chromatographed (silica gel, CH₂Cl₂/MeOH = 10:1), to afford 0.17 g of the desired product (0.170 g, 0.38 mmol, 95%). 1H NMR (CDCI₃, 400 MHz) δ 7.80 (bs, 1 H, NH), 7.46 (d, 1 H, J= 6.8

Hz), 7.31 (d, 1 H, J= 8.0 Hz), 7.14 (dt, 1 H, Jj = 6.8 Hz, J₂ = 1.2 Hz), 7.09 (dt,

1 H, Jj = 7.6 Hz, J₂ = 1.2 Hz) 4.46 (bs, 1 H, H-3), 3.79 (s, 3 H, OMe), 3.62-3.48 (m, 5 H, 1 OMe and 2 H), 3.26-3.15 (m, 2 H), 3.06-2.91 (m, 2 H), 2.59-2.45 (m,

3 H), 2.32-2.17 (m, 2 H), 2.03-1.91 (m, 1 H), 1.89-1.71 (m, 3 H); ¹³C-NMR (CDCI₃, 100 MHz) δ 173.7, 135.7, 132.1, 127.8, 121.7, 119.7, 118.3, 111.1, 108.3, 81.6, 75.3, 61.2, 53.9, 52.1, 51.5, 51.3, 49.5, 34.7, 33.0, 32.4, 24.5, 16.9. Example 7. Synthesis of deserpidine Methyl deserpidate (0.5 g, 1.30 mmol) was dissolved under nitrogen in dry pyridine (4.0 ml). 3,4,5-Trimethoxybenzoyl chloride (0.5 g, 2.17 mmol) was dissolved in benzene (2 ml), then dropped slowly in the reaction mixture. The reaction was kept under stirring for 5 days at 5°C and then quenched with 50 ml of water. This solution was added with a mixture of concentrated NH₃ (2 ml) in 10 ml of H₂0. The solution was then extracted with CH₂C1₂ (3 x 25 ml) and the organic phase was dried and filtered. The solvent was evaporated under vacuum and the resulting residue was recrystallized from acetone, to afford 0.168 g (0.440 mmol, 91%) of the desired product. 1H-NMR (CDC1₃, 400 MHz) δ 7.83 (bs, 1 H, NH), 7.48 (1 H), 7.33 (s, 1 H), 7.33 (s, 1 H), 7.32 (1 H), 7.17 (1 H), 7.12 (1 H), 5.07 (1 H), 4.52 (bs, 1 H, H-3), 3.90 (dd, 1 H, Jj = 12 Hz, J₂ = 9 Hz), 3.89 (s, 3 H, OMe), 3.89 (s, 3 H, OMe), 3.89 (s, 3 H, OMe), 3.80 (s, 3 H, OMe), 3.80 (s, 3 H, OMe), 3.20 (m, 1 H), 3.20 (m, 1 H), 3.04 (dd, 1 H, Jj = 12 Hz, J₂ = Hz), 2.98 (1 H), 2.70 (dd, 1 H, Jj = 12 Hz, J₂ = 5 Hz), 2.54 (1 H), 2.47 (dd, 1 H, J_l = 12 Hz, J₂ = 2 Hz), 2.34 (m, 1 H), 2.33 (1 H), 2.04 (1 H), 1.98 (1 H), 1.90 (1 H), 1.86 (1 H); ¹³C-NMR (CDCI₃, 100 MHz) δ 176.8, 169.4, 163.8, 161.0, 159.4, 144.0, 141.6, 141.6, 141.4, 140.1. 137.4, 133.1, 133.0, 115.5, 115.5, 86.2, 85.5, 82.3, 75.4, 74.0, 72.1, 67.8, 65.3, 61.8, 57.2, 50.7, 39.8, 27.3, 20.3.

Claims

1. A process for the preparation of deserpidine (la)

comprising the following steps: a) demethylation of reserpic acid lactone (II)

to give 11-0-demethyl reserpic acid lactone (III)

b) conversion of compound (III) to deserpidic acid lactone (V)

c) hydrolisis of deserpidic acid lactone (V) to methyl deserpidate (VI)

d) esterification of methyl deserpidate (VI) with 3,4,5-trimetoxybenzoic acid to give deserpidine (la).

2. The process as claimed in claim 1 wherein the conversion of compound (III) to deserpidic acid lactone (V) is carried out trasforming compound (III) into a compound of formula (IV)

in which R' is a leaving group and reducing compound (IV). \

3. The process as claimed in claim 2 in which in compound (IV) the R' group is selected from a sulfonate, an isoureido or a (5-phenyl-tetrazolyl)oxy group.

4. The process as claimed in claim 3 in which the R' group is />-toluenesulfonate or methanesulfonate.

5. The process as claimed in claim 4 in which the R' group is /7-toluenesulfonate .

6. The process as claimed in claim 5 in which the reduction of compound (IV) is carried out with nickel Raney.

7. The process as claimed in claim 3 in which the R' group is an isoureido group.

8. The process as claimed in claim 7 in which the reduction of compound (IV) is carried out with palladium on charcoal.

9. The compound of formula (III)

10. A compound of formula (IV)

in which R' is />-toluenesulfonate.